Vuzix Corporation - Common Stock (VUZI)

Vuzix (VUZI) Q4 2025 Earnings Call Transcript

Let's have a look at what is happening on the US markets in the middle of the day on Tuesday. Below you can find the top gainers and losers in today's session.

Vuzix Q3 2025 earnings miss revenue estimates, causing a stock dip. The company also secures a $5M investment and appoints a new enterprise president.

Vuzix Corp partners with BUNDLAR to deliver no-code XR content to smart glasses for enterprise & government markets.

VUZIX Q2 2025 earnings miss revenue estimates ($1.3M vs. $1.66M) but report narrower EPS loss (-$0.10 vs. -$0.1224). Stock dips 0.46% post-announcement.

Augmex, a Netherlands-based company, will integrate its software solutions with Vuzix’s smart glasses for its supply chain customers in the UK and Europe.

VUZI earnings call for the period ending December 31, 2024.

Vuzix, GeoVox Labs, and Cardiol Therapeutics emerged as notable penny stocks late in 2024 for their potential to scale operations and launch new products.

VUZI earnings call for the period ending September 30, 2024.